Dose patients increasing

Dopaminergic mechanisms within the ventral striatum (i.e., nucleus accumbens) subserve the ability of amphetamine and methylphenidate in low to moderate doses to increase locomotor activity. In contrast, very low dosages in animals seem to cause hypoactivity presumably by stimulation of autoreceptors, a finding that would be compatible with the clinical impression that methylphenidate might be usefiil in some patients with mania. 

Medications should be started at the lowest dose and increased gradually based on the patient s symptoms (Table 29-1). When interviewing patients, ask the following questions for each scheduled dose before adjusting the dose or timing of medications ... 

Evidence does exist that small differences in the LT4 dose can result in large changes in TSH. The impact on TSH of small changes in LT4 dose was assessed in 21 adult hypothyroid patients.21 When the daily dose was reduced by 25 meg, 78% had an elevated TSH level. When the daily dose was increased by 25 meg, 55% had a low TSH level. Clearly, differences in the LT4 dose or bioavailability within the FDA-allowed variance for bioequivalent products can cause significant changes in TSH. 

Patients should always start with the lowest recommended dose and increase slowly to avoid overdosing. Follow-up with the patient is necessary to evaluate whether the dietary supplement is safe and effective. Report any suspected adverse event to FDA s Medwatch, 1-800-FDA-1088. FDA has developed the Special Nutritionals Adverse Event Monitoring System (SN/AEMS), a database of adverse events associated with the use of special nutritional products dietary supplements, infant formulas, and medical foods. ... 

Respiratory depression increases progressively as doses are increased. It often manifests as a decrease in respiratory rate, and the cough reflex is also depressed. Patients with underlying pulmonary dysfunction are at risk for increased respiratory compromise. Respiratory depression can be reversed by naloxone. 

Doses can be started at 400 mg to 600 mg/day in divided doses, and increased by 200 mg/day every 2 to 4 days up to 10 to 15 mg/kg/day. Outpatients should be titrated upward more slowly to avoid side effects. Many patients are able to tolerate once daily dosing once their mood episode has stabilized. 

Elderly patients should receive one-half the initial dose given to younger adults, and the dose is increased at a slower rate. The elderly may require 6 to 12 weeks of treatment to achieve the desired antidepressant response. 

In a Phase la study in healthy volunteers, ARRY-438162 was well tolerated up to 20mg/kg q.d. oral dose. There was a dose proportional increase in plasma concentration and decrease in the production of IL-1 ft, TNFa, IL-6 and pERK in the ex-vivo-stimulated whole blood from drug treated volunteers. Array has initiated a Phase lb study of ARRY-438162 in combination with methotrexate in rheumatoid arthritis patients with the goals of assessing safety, tolerability, pharmacokinetics (PK), biomarkers and initial signs of efficacy. 

Thioridazine (Mellaril). The potency and effects of thioridazine are very similar to chlorpromazine. It should also be started at a relatively low dose and increased stepwise to help patients become adjusted to its effects. 

Let s examine a sample case study. A patient who has been taking haloperidol (Haldol) lOmg a day for several years may well have developed tardive dyskinesia. What would happen if the dose were increased to 20 mg a day When we see the... 

Gentamicin, as with other aminoglycosides, is excreted through the kidney, and in renal impairment there is the risk of accumulation. Consequently doses are reduced and dosing interval increased in patients with renal impairment. 

Cardiac conduction Flecainide slows cardiac conduction in most patients to produce dose-related increases in PR, QRS, and QT intervals. The degree of lengthening of PR and QRS intervals does not predict either efficacy or the development of cardiac adverse effects. Patients may develop new first-degree AV heart block. Use caution and consider dose reductions. The JT interval (QT minus QRS) only widens approximately 4% on the average. Rare cases of torsade de pointes-type arrhythmias have occurred. 

Subsequent doses Slowly increase the dose to achieve the desired blood pressure response. The recommended dose range is 1 to 5 mg daily however, some patients may benefit from doses as high as 20 mg/day. If response is substantially diminished at 24 hours, consider an increased dose or a twice-daily regimen. 

Acute symptoms requiring rapid theophyllinization in patients receiving theophylline - Each 0.5 mg/kg theophylline administered as a loading dose will increase the serum theophylline concentration by approximately 1 mcg/mL. Ideally, defer the loading dose if a serum theophylline concentration can be obtained rapidly. 

---